- Home
- BSET vs UNCY Comparison
BSET vs UNCY Comparison
Compare BSET & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | UNCY |
|---|---|---|
| Founded | 1902 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.9M | 150.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSET | UNCY |
|---|---|---|
| Price | $17.17 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 15.0K | ★ 757.3K |
| Earning Date | 04-01-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.49% | N/A |
| EPS Growth | ★ 163.06 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $456,855,000.00 | $675,000.00 |
| Revenue This Year | $1.72 | N/A |
| Revenue Next Year | $3.78 | $582.86 |
| P/E Ratio | $46.73 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.17 | $3.72 |
| 52 Week High | $22.26 | $8.74 |
Technical Indicators
Market Signals| Indicator | BSET | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 34.49 | 39.91 |
| Support Level | $14.13 | $4.81 |
| Resistance Level | $19.31 | $5.86 |
| Average True Range (ATR) | 0.52 | 0.21 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 15.87 | 8.56 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.